DE69814441D1 - 6,11-verbrückte erythromycinderivate - Google Patents

6,11-verbrückte erythromycinderivate

Info

Publication number
DE69814441D1
DE69814441D1 DE69814441T DE69814441T DE69814441D1 DE 69814441 D1 DE69814441 D1 DE 69814441D1 DE 69814441 T DE69814441 T DE 69814441T DE 69814441 T DE69814441 T DE 69814441T DE 69814441 D1 DE69814441 D1 DE 69814441D1
Authority
DE
Germany
Prior art keywords
bridged
erythromycine
derivatives
erythromycine derivatives
bridged erythromycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69814441T
Other languages
English (en)
Other versions
DE69814441T2 (de
Inventor
Sun Or
George Griesgraber
Leping Li
T Chu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69814441D1 publication Critical patent/DE69814441D1/de
Application granted granted Critical
Publication of DE69814441T2 publication Critical patent/DE69814441T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
DE69814441T 1997-10-29 1998-10-29 6,11-verbrückte erythromycinderivate Expired - Fee Related DE69814441T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US960400 1997-10-29
US15826998A 1998-09-22 1998-09-22
US158269 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (2)

Publication Number Publication Date
DE69814441D1 true DE69814441D1 (de) 2003-06-12
DE69814441T2 DE69814441T2 (de) 2004-04-08

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69814441T Expired - Fee Related DE69814441T2 (de) 1997-10-29 1998-10-29 6,11-verbrückte erythromycinderivate

Country Status (23)

Country Link
EP (1) EP1027361B1 (de)
JP (1) JP2001521038A (de)
KR (1) KR20010031591A (de)
CN (1) CN1278266A (de)
AR (1) AR015986A1 (de)
AT (1) ATE239750T1 (de)
AU (1) AU1286799A (de)
BG (1) BG104425A (de)
BR (1) BR9813317A (de)
CA (1) CA2307828A1 (de)
CO (1) CO4990972A1 (de)
DE (1) DE69814441T2 (de)
DK (1) DK1027361T3 (de)
ES (1) ES2198766T3 (de)
HU (1) HUP0004323A2 (de)
IL (1) IL134996A0 (de)
NO (1) NO20002099L (de)
PL (1) PL340253A1 (de)
PT (1) PT1027361E (de)
SK (1) SK6342000A3 (de)
TR (1) TR200001140T2 (de)
TW (1) TW486485B (de)
WO (1) WO1999021864A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
JP2005503416A (ja) 2001-09-17 2005-02-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ６−ｏ−カルバメート−１１，１２−ラクト−ケトライド抗菌剤
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
US6753318B1 (en) * 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
AU2003229037B8 (en) * 2002-05-13 2009-07-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
NZ536402A (en) 2002-05-13 2006-08-31 Enanta Pharm Inc 6,11 bicyclic erythromycin derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990067492A (ko) * 1995-11-08 1999-08-25 스티븐 에프. 웨인스톡 트리사이클릭 에리트로마이신 유도체

Also Published As

Publication number Publication date
CO4990972A1 (es) 2000-12-26
ES2198766T3 (es) 2004-02-01
CN1278266A (zh) 2000-12-27
PT1027361E (pt) 2003-09-30
DK1027361T3 (da) 2003-08-25
TW486485B (en) 2002-05-11
JP2001521038A (ja) 2001-11-06
BR9813317A (pt) 2000-08-22
NO20002099L (no) 2000-06-29
EP1027361B1 (de) 2003-05-07
KR20010031591A (ko) 2001-04-16
AR015986A1 (es) 2001-05-30
TR200001140T2 (tr) 2001-05-21
DE69814441T2 (de) 2004-04-08
BG104425A (bg) 2001-01-31
NO20002099D0 (no) 2000-04-25
PL340253A1 (en) 2001-01-29
CA2307828A1 (en) 1999-05-06
HUP0004323A2 (hu) 2001-02-28
EP1027361A1 (de) 2000-08-16
WO1999021864A1 (en) 1999-05-06
ATE239750T1 (de) 2003-05-15
AU1286799A (en) 1999-05-17
SK6342000A3 (en) 2000-09-12
IL134996A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
PT901474E (pt) Derivados de aril-pirimidina.
NL300214I1 (nl) Chinazolinederivaten.
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
TR199600883A2 (tr) Pürin-6-on türevleri.
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
TR199802520A3 (tr) 1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
TR199600715A2 (tr) Kefalosforin türevleri.
EE04089B1 (et) 1,3,4-oksadiasolooni derivaadid
TR199700354A3 (tr) Karbohidrat türevleri.
DE69906149D1 (de) 4,5-azolo-oxindole
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
TR28915A (tr) Naftokinon türevleri.
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
TR199700927A3 (tr) N-Benzilazolyum türevleri.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee